Michael Wechsler, MD

 


Michael Wechsler, MD
Curriculum Vitae (pdf file)

Dr. Michael Wechsler is a Professor of Medicine in the Division of Pulmonary, Critical Care & Sleep Medicine of the Department of Medicine at National Jewish Health in Denver and is board certified in Pulmonary & Critical Care Medicine. 
Prior to his current position as Director of Asthma at National Jewish Health in Denver, Dr. Wechsler was on faculty at Harvard Medical School and served as Associate Director of the Brigham & Women’s Hospital Asthma Research Center, where he designed and led clinical trials in asthma and eosinophilic lung diseases. He has expertise in phenotyping asthma subjects and experience in investigating patients with severe asthma.  He has more than 80 peer-reviewed publications, almost all relating to asthma, Churg-Strauss Syndrome, or eosinophilic lung diseases, in journals including the New England Journal of Medicine, the Lancet, and JAMA.  His particular research interests have been related to clinical and translational asthma & therapeutics, asthma pharmacogenomics, and the treatment and management of Churg-Strauss syndrome (CSS).  He is recognized as an international leader in CSS and eosinophilic lung diseases, treating one of the largest cohorts of patients with this disorder in the US. He has been an investigator in the NHLBI Asthma Clinical Research Network (ACRN) (now known as AsthmaNet), the NHLBI-sponsored Severe Asthma Research Program (SARP), and an NHLBI grant examining imatinib in severe asthma. He has expertise in clinical trial design and management, including serving as PI in a recent multi-center NHLBI/ACRN trial examining asthma pharmacogenomics (LARGE (Wechsler Lancet 2010), serving as PI in an NIH study examining the role of placebo in asthma (Wechsler NEJM 2011), and currently serving as PI of a large multi-center AHRQ funded study examining treatment of asthma in Blacks. He has participated in many different task forces related to the study of eosinophilic lung diseases (including CSS) that have been sponsored by the NIH, the FDA, the European Respiratory Society and the International Eosinophil Society. 

Clinically, Dr. Wechsler has an active outpatient practice at National Jewish Health in which he primarily sees patients with Churg-Strauss syndrome, eosinophilic pneumonia and severe refractory asthma. He also practices critical care medicine in Denver’s Rose Hospital Medical Intensive Care Unit where he enjoys teaching medical students, residents, and fellows. Dr. Wechsler also serves as Associate Editor of the Journal Allergy and is on the editorial Board of the European Journal of Clinical Investigation

Dr. Wechsler received his undergraduate degree in Biochemical Sciences from Harvard College, his medical education from McGill University in Montreal, a Masters in Medical Science from Harvard Medical School, and completed postgraduate internal medicine training at Harvard’s Beth Israel Hospital in Boston and his pulmonary training at the Harvard Combined Fellowship in Pulmonary & Critical Care Medicine.

 

1750 Tysons Blvd.
Suite 1500
McLean, VA 22102

Phone:  +1 202 965 2288
Fax:      +1 202 747 3415
Email:    [email protected]

 

 

 

 

 

Visit our Blog

Follow us on Twitter

Our History

Executive Management

Support Team

Business Solutions & Innovation

Digital Communications

Clinical Advisors

Allergy Advisors

Pulmonary Advisors
ENT Advisors

Ocular Advisors

Emergency Medicine Advisors

Health Outcomes Advisors

Reproductive Endocrinology and Genetics Advisors

Behavioral Health Advisors

Aesthetics

Respiratory - Europe Advisors
Strategic Planning

Product Support

Professional Marketing

Conference Publications

Regulatory Strategy & Support

Strategic Clinical Development



Visit our Blog | Follow us on Twitter
This website was developed and is managed by DICODEA
© 2004-2021 Strategic Pharmaceutical Advisors. All Rights Reserved